Sign In
Buy ELTP
$0.365
-0.0101 (-2.69%)
At Close: Aug 04, 2026
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
07:00am, Monday, 16'th Jun 2025
Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufac
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
07:00am, Monday, 16'th Jun 2025
Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufac
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
04:30pm, Wednesday, 30'th Apr 2025
Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
07:00am, Monday, 03'rd Mar 2025
Northvale, New Jersey--(Newsfile Corp. - March 3, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, an
ELTP Stock Falls Following Q3 Earnings Decline, Revenue Down Y/Y
11:05am, Wednesday, 19'th Feb 2025
Elite Pharmaceuticals' third-quarter fiscal 2025 reports a revenue drop and a net loss. However, delayed shipments impact results.
Conference Call Scheduled for Friday, February 14 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - February 13, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a
Financials for the Third Quarter of Fiscal Year 2025 Ended December 31, 2024 will be released on Thursday, February 13, 2025 Northvale, New Jersey--(Newsfile Corp. - February 10, 2025) - Elite Pharmac
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
07:00am, Thursday, 26'th Dec 2024
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
06:00am, Monday, 02'nd Dec 2024
Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Two Smaller Companies Worthy of Your "Attention"
03:37pm, Monday, 25'th Nov 2024
Here we highlight a small cap and a microcap with Zacks Outperform ratings.
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline
01:05pm, Monday, 18'th Nov 2024
ELTP sees strong revenue growth despite a net loss, driven by new product launches and strategic acquisitions.
Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
06:00am, Monday, 18'th Nov 2024
Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manuf
Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call Transcript
03:24pm, Saturday, 16'th Nov 2024
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2025 Earnings Conference Call November 15, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO Conference Call Particip
Conference Call Scheduled for Friday, November 15 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - November 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a
Financials for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 will be released on Thursday, November 14, 2024 Northvale, New Jersey--(Newsfile Corp. - November 7, 2024) - Elite Pharma
